kynurenic acid has been researched along with nitroarginine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Czachurski, J; Seller, H; Zanzinger, J | 1 |
Beitz, AJ; Clark, HB; Feddersen, RM; Iadecola, C; Yang, G; Zhang, F | 1 |
Bonnier, C; Delpech, A; Evrard, P; Gressens, P; Marret, S; Raymackers, JM | 1 |
Gemignani, A; Paudice, P; Pittaluga, A; Raiteri, M | 1 |
Farkas, T; Nagy, D; Robotka, H; Rozsa, E; Sas, K; Toldi, J; Vecsei, L | 1 |
6 other study(ies) available for kynurenic acid and nitroarginine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Effects of nitric oxide on sympathetic baroreflex transmission in the nucleus tractus solitarii and caudal ventrolateral medulla in cats.
Topics: Animals; Arginine; Baroreflex; Carotid Sinus; Cats; Electric Stimulation; Glutamic Acid; Kidney; Kynurenic Acid; Medulla Oblongata; Neural Inhibition; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Sympathetic Nervous System; Synaptic Transmission | 1995 |
Cerebellar vascular and synaptic responses in normal mice and in transgenics with Purkinje cell dysfunction.
Topics: Action Potentials; Animals; Blood Flow Velocity; Cerebellum; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Kynurenic Acid; Laser-Doppler Flowmetry; Mice; Mice, Transgenic; Microscopy, Electron; Nitric Oxide Synthase; Nitroarginine; Purkinje Cells; Quinoxalines; Receptors, AMPA; Synapses | 1998 |
Glycine antagonist and NO synthase inhibitor protect the developing mouse brain against neonatal excitotoxic lesions.
Topics: Animals; Animals, Newborn; Brain; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Humans; Kynurenic Acid; Mice; Nitric Oxide Synthase; Nitroarginine | 1999 |
The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cerebral Cortex; Cholecystokinin; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; HIV Envelope Protein gp120; HIV-1; Indoles; Kynurenic Acid; Male; Maleimides; Neurons; Nitroarginine; Peptide Fragments; Pipecolic Acids; Piperazines; Piperidines; Potassium; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Somatostatin; Synaptic Transmission; Synaptosomes; Zinc | 2000 |
The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.
Topics: Animals; Convulsants; Dose-Response Relationship, Drug; Electrophysiology; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; GABA Antagonists; Hippocampus; Kynurenic Acid; Kynurenine; Nitroarginine; Pentylenetetrazole; Rats; Rats, Wistar | 2008 |